NEW STEP BY STEP MAP FOR PYRROLOQUINOLINE QUINONE DISODIUM SALT

So, whilst we demonstrate that mixture therapies involving CX-5461 have promising anti-tumor activity in vivo in neuroblastoma, our identification of TOP2B as the main goal of CX-5461 implies unforeseen protection worries that should be examined in ongoing section II clinical trials in adult individuals in advance of pursuing scientific studies in